Elite Pharma Stock Price To Earnings To Growth
ELTPDelisted Stock | USD 0.04 0 6.75% |
Elite Pharma fundamentals help investors to digest information that contributes to Elite Pharma's financial success or failures. It also enables traders to predict the movement of Elite OTC Stock. The fundamental analysis module provides a way to measure Elite Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Elite Pharma otc stock.
Elite |
Elite Pharma OTC Stock Price To Earnings To Growth Analysis
Elite Pharma's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
CompetitionBased on the latest financial disclosure, Elite Pharma has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Pharmaceuticals sector and about the same as Health Care (which currently averages 0.0) industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
All Next | Launch Module |
Elite Fundamentals
Return On Equity | 0.27 | ||||
Return On Asset | 0.0739 | ||||
Profit Margin | 0.20 % | ||||
Operating Margin | 0.15 % | ||||
Current Valuation | 27.92 M | ||||
Shares Outstanding | 1.01 B | ||||
Shares Owned By Insiders | 17.53 % | ||||
Shares Owned By Institutions | 0.06 % | ||||
Number Of Shares Shorted | 757.07 K | ||||
Price To Earning | 5.21 X | ||||
Price To Book | 1.12 X | ||||
Price To Sales | 0.92 X | ||||
Revenue | 32.26 M | ||||
Gross Profit | 14.8 M | ||||
EBITDA | 7.93 M | ||||
Net Income | 8.9 M | ||||
Cash And Equivalents | 19.78 M | ||||
Cash Per Share | 0.02 X | ||||
Total Debt | 1.39 M | ||||
Debt To Equity | 0.57 % | ||||
Current Ratio | 4.50 X | ||||
Book Value Per Share | 0.03 X | ||||
Cash Flow From Operations | 6.51 M | ||||
Short Ratio | 0.87 X | ||||
Earnings Per Share | 0.01 X | ||||
Target Price | 4.0 | ||||
Number Of Employees | 43 | ||||
Beta | 0.29 | ||||
Market Capitalization | 38.53 M | ||||
Total Asset | 35.15 M | ||||
Retained Earnings | (147.41 M) | ||||
Working Capital | 14.53 M | ||||
Current Asset | 19.66 M | ||||
Current Liabilities | 5.13 M | ||||
Z Score | 10.6 | ||||
Net Asset | 35.15 M |
About Elite Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Elite Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Elite Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Elite Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Elite Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elite Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elite Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Elite OTC Stock
Moving against Elite OTC Stock
0.73 | OGI | OrganiGram Holdings Fiscal Year End 17th of December 2024 | PairCorr |
0.71 | HLN | Haleon plc | PairCorr |
0.68 | EGRX | Eagle Pharmaceuticals | PairCorr |
0.67 | ACB | Aurora Cannabis | PairCorr |
0.6 | DRRX | Durect | PairCorr |
The ability to find closely correlated positions to Elite Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elite Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elite Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elite Pharma to buy it.
The correlation of Elite Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elite Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elite Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Elite Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Elite OTC Stock
If you are still planning to invest in Elite Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Elite Pharma's history and understand the potential risks before investing.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |